Arkansas State Board of Pharmacy 101 East Capitol, Suite 218 Little Rock, AR 72201 501-682-0190 Fax 501-682-0195 www.arkansas.gov/asbp Hospital Pharmacy Inspection Survey DATE: FACILITY: ADDRESS: COUNTY: DIRECTOR: LICENSE: PHARMACY PERMIT #: DEA #: EXP.: DEA POWER OF ATTORNEY: ADMINISTRATOR: DON: LICENSED BEDS: AVG. CENSUS: LENGTH OF STAY: DRUG SYSTEM: DRUG STORAGE AREAS: Pharmacy Hours: M-F: S & S: Hours/week: Pharmacist’s schedule of visits: YES NO N/A Pharmacy administered in accordance with accepted professional principles Pharmacist trained in hospital pharmacy operations Training/experience Pharmacist responsible for control of all medications and pharmacy services Oral/telephone orders signed within 24 hours Physical facilities provided for all pharmacy operations and storage of drugs Proper lighting, ventilation and temperature controls Special locked storage provided for controlled substances, bulk alcohol and drugs Provision for emergency pharmacy services/after hours NOTES: 1 of 13 YES NO N/A Pharmacist oversees all compounding and dispensing Supportive personnel perform technical functions to assist pharmacist. The pharmacist supervises these functions and assumes responsibility. Final check and verification certified by Pharmacist’s signature, initials, or other ID mark. Drugs issued to all floor units in accordance with approved policies & procedures Floor stocks properly controlled Approved stock lists stating quantities (exact or range) posted in drug area and included in Policy and Procedure Manual All drug storage areas checked monthly by Pharmacy Services Documentation: Temperature of drug & biological storage refrigerator(s) documented daily 36 to 46 degrees F (2 to 8 degrees C) Controlled substances verified for accuracy periodically: Pharmacy: Floor Stock: ER: Other locations: Abuses and losses of controlled substances reported in accordance with Federal and State law to appropriate individuals Proper equipment available for compounding and dispensing: Graduates 0.1 ml to 500 ml Mortars & pestles Hot and cold running water Spatulas (steel and non-metal) Funnels Stirring rods Class A balance and appropriate weights Typewriter or other label printer Apparatus for small volume sterile solutions Suitable containers and labels Laminar Flow Hood Last Inspection Date: Cleaning/log: IV Admixtures: Pharmacists: Technicians: Nurses: NOTES: 2 of 13 YES NO N/A Inpatient labels—name & strength of medication—expiration date—lot or control number - label or container into which medication is placed bear name & room number of patient Outpatient labels - patient name - date – prescriber – directions - name & strength of medication (unless directed otherwise by prescriber) Adequate reference library includes: American Hospital Formulary Service Pharmacology text USP DI (3VOL) & Advice for Patient or Facts & Comparisons and Drug Facts For Patients Compatibility of parenteral products text Current professional journals Repackaged medications - records maintained Packages and labels: Verification: Expiration dating: Unused medications (except U/D) destroyed rather than returned to stock Deteriorated, damaged, or outdated medications destroyed or returned for credit Unusable controlled substances returned to ADH for destruction Date of last shipment: Medication errors & adverse drug reactions reported to Pharmacy for review Discharge medications consistent with immediate medical needs of patient Adequate number of personnel to ensure quality services Director: Interns/Residents: Assistant Director: Technicians: Staff Pharmacists: Clerical Personnel: Technicians are licensed, properly trained & under the direct supervision of pharmacist performing only allowed duties Staffing each week complies with allowed ratio In-services documented: CE documented: NOTES: 3 of 13 YES NO N/A Records maintained for requisitioning & dispensing of medications Records maintained to effectively & accurately charge patients Records kept of transactions of Pharmacy (New Rx, refills, floor stock, IV, etc.) Records maintained by Pharmacy separate from other hospital records for each (in and out) patient to include - full name of patient – prescriber - name and strength of medication - manufacturer or tradename – quantity - Pharmacist’s initials. Should also reflect medications returned MAR accurately reflects drug administered when generics substituted for trade names that are ordered Records of procurement, stock on hand, & dispensing of controlled substances maintained & readily retrievable in a manner to afford readily traced disposition of any item Sell to another registrant: Profiles clearly marked: Wastage recorded & witnessed: Controlled substances stored properly, inventoried and accounted for Date of Last DEA Inventory: Controlled substances in specialty areas not staffed by licensed personnel each shift are counted on each shift covered by licensed personnel. All records and inventories of Schedule II items stored separately All drug records maintained in a readily retrievable manner for at least two years NOTES: 4 of 13 PHARMACY & THERAPEUTICS COMMITTEE YES NO N/A A committee or equivalent to include at least one physician, the Administrator or a designated representative, DON or designated representative, & the Pharmacist is established in the hospital. Committee meets at least quarterly and minutes are kept Dates of meetings: Committee assists in formulation of broad policies & procedures regarding evaluation, appraisal, selection, procurement, storage, distribution, use, safety procedures, and all matters relating to medications in hospital & advises the medical staff and Pharmacist Composition, function, frequency should be in Medical Staff Bylaws and the Pharmacy Policy and Procedure Manual Pharmacy Policy & Procedure Manual is approved on an annual basis. This can be done by the Director of Pharmacy Date: Pharmacist with aid of P & T Committee is responsible for specifications as to quality, quantity, and source of all medications Committee develops, reviews & amends periodically a formulary or drug list The formulary or drug list is approved annually Date: Committee makes recommendations on medications to be stocked at nursing units and as emergency stocks. Floor stock lists & emergency drug lists are approved annually Date: Committee evaluates clinical data concerning new medications or preparations requested for use in the hospital. Committee monitors & controls use of antibiotics for prevention and use of antibiotics in the presence of infection Committee discusses reports of medication errors as to types & trends; conclusions & recommendations are made Committee discusses reports of adverse drug reactions and makes recommendations for preventive action (If neither of the above have occurred, this is so stated in the minutes) Committee implements & follows a policy for use & control of investigational drugs & research in the use of recognized medications NOTES: 5 of 13 YES NO N/A Committee implements a policy on all toxic or dangerous drugs as to automatic stop orders. Policy is monitored & enforced. C-II injectables: C-II oral: C-3,4-5: Toradol (Ketorolac): Antibiotics: Cortisones: Anticoagulants: Oxytocics: Antineoplastics: PATIENT ID # MEDICATION DATE ORDERED LAST DOSE # DAYS LATE 6 of 13 POLICIES & PROCEDURES YES NO N/A Policies & procedures are maintained, updated, and revised Date Job descriptions, duties, responsibilities, & minimum requirements Procurement, storage, distribution, & drug control Charging patients (what record used, who performs) Records Labeling Back-up stock—list—log or record—labeling Obtaining medications after hours Floor stock, requisitioning, with limits stocked Emergency room patient medications Emergency kits/carts—lists of medications & replacements Medications brought in by patients Bedside medications Drug recall Destruction of medication Destruction of controlled substances in facility Storage of controlled substances in facility Controlled substance audits—reporting discrepancies Discharge—outpatient—employee prescriptions Investigational drugs—if not allowed, so stated Medication errors----adverse drug reactions Child resistant packaging for discharge—outpatient—employee—ER prescriptions IV Hood Time on: Cleaning: Inspection: PPIs—Estrogens, progestational medications, etc. Multi-dose vials Repackaging---labeling---dating MAR reflects actual medication administered Samples Herbal and Nutraceutical Agents Sound Alike/Look Alike Medications High Alert/ High Risk Medications NOTES: 7 of 13 YES NO N/A Physician in ER is on call or in hours All dispensing by physician or nurses with pre-dispensed doses Medications dispensed from ER limited to 48 hour supply Patients assessed—written orders for all medications administered/dispensed Prescription pads are secured Pharmacy gets record of medications administered or dispensed or reviews log Back-up stock Location: Labels complete with lot # and expiration date Pharmacy checks medications against prescriber’s orders Methods of signing out medications: Who handles take home X-ray preparations: Properly labeled and packaged Routine orders for preparations Hospital based ambulance service Does hospital supply medications? Who receives them? Record of issuance: Signed order received & maintained by hospital as record of disposition Medications properly secured & stored at proper temperatures Private physician clinics in hospital Medication provided Written procedure for medications Who supplies medication On what record are medications ordered: Signed orders Specialty units (EEG, Cardiac, Cath, etc.) with medications Who administers medications? Where are orders recorded and signed by prescriber? Where are medications charted & initialed? NOTES: 8 of 13 TECHNICIANS YES NO N/A Pharmacist is physically present to observe, direct, and supervise technicians at all times the technician performs approved duties. Pharmacist is totally and absolutely responsible for technician’s actions. Documentation by each technician of all duties and tasks performed in the preparation and processing of medications. Pharmacist is responsible for final check and verification. Performance, check and verification are recorded on a record maintained by the department which includes signature, initials, or other identifying mark of each person. ELECTRONIC DATA PROCESSING YES NO N/A System is approved by Arkansas State Board of Pharmacy Input may be performed by Pharmacist or technician. Final verification made by Supervising Pharmacist. Judgmental decisions made only by Pharmacist. Patient medication profile may be on line or hard copy. Final copy maintained Name, ID #, prescriber, drug name, strength, and dosage form, # of doses issued, initials, name, or ID of PD approving order, & order date Hard copy of daily medication printout is required. Date, patient name, ID #, drug name, strength & dosage form, # issued, & the initials of PD who checked Print out of daily log signed by all Pharmacists filling orders. May be replaced by a monthly log containing same information. May use a bound log book with attestation statement. Include times started and finished. Keep for 2 years. Confidentiality is assured Hard copy printout of all reports are available within 48 hours Auxiliary record keeping system in place in lieu of breakdown EMPLOYEE PRESCRIPTIONS YES NO N/A Schedule IIs kept separate Proper information recorded Date & signature of dispensing Pharmacist Name, address of patient, address & DEA # of prescriber NOTES: 9 of 13 NURSING UNITS 1. LOCKED STORAGE a. Area locked when unattended 2. CONTROLLED SUBSTANCES a. Locked separately b. Double locked c. On disposition sheets d. Two nurses count & sign e. Wastage recorded f. Wastage witnessed g. Errors marked correctly h. Patient’s full name i. Nurse’s full name & title 3. REFRIGERATOR a. Temperature checked and documented b. Proper drugs refrigerated c. Drugs separated from food 4. DATED DRUGS CURRENT 5. APPROVED STOCK LIST POSTED 6. CRASH CART OR KIT a. List on outside b. Sealed NOTES: 10 of 13 HOSPITAL PHARMACY SERVICES SURVEY DIRECTOR OF PHARMACY LICENSE # ASSISTANT DIRECTOR LICENSE # STAFF PHARMACIST LICENSE # LICENSE # LICENSE # LICENSE # LICENSE # LICENSE # PHARMACY TECHNICIAN LICENSE # LICENSE # LICENSE # LICENSE # LICENSE # LICENSE # LICENSE # LICENSE # 11 of 13 PHARMACEUTICAL COMPOUNDING OF STERILE PREPARATIONS YES NO N/A Policies, procedures, and operational guidance are maintained, communicated, and adhered to by all personnel responsible for compounding sterile preparations (CSP’s) including hazardous drugs, and in packaging and labeling sterile medications. Pharmacy personnel are oriented, trained, and demonstrate competency in CSP’s, including hazardous drugs, and in packaging and labeling compounded sterile preparations. Pharmacists assign the appropriate risk level (low, medium, or high) for each compounding activity based on adequate knowledge and experience in good sterile compounding practices. Pharmacists assign the appropriate risk level (low, medium, or high) for each compounding activity based on adequate knowledge and experience in good sterile compounding practices. Pharmacist select beyond-use date based on the results of direct stability testing or extrapolation from reliable literature source. CSP’s are properly labeled with the following: names and amounts or concentrations of all ingredients, total volume, beyond-use date, appropriate route of administration, storage conditions and other information for safe use. CSP’s are visually inspected for physical integrity and expected appearance, including final fill amount, after compounding and again during dispensing. CSP’s are properly stored if not immediately dispensed for administration. Compounding sterile preparations in ISO Class 5 (Class 100 hood) controlled environments. Surfaces of ceilings, walls, floors, fixtures, carts, shelving, counters, and cabinets in the buffer zone or room are smooth, impervious free from cracks and crevices, nonshedding and resistant to sanitizing agents. Does the buffer zone or room contain sinks or floor drains? Within the ante area or anteroom, supplies for compounding are uncartoned and disinfected. No shipping or other external cartons are taken into the buffer zone or room. Objects that shed particles are not brought into the buffer zone or room, including pencils, cardboard cartons, paper towels and cotton items. Only nonshedding paper related products can be brought into the buffer zone or room. Floors in the buffer zone or room are cleansed by mopping once daily during a time when no aseptic compounding is in progress. Floor cleaning begins in the buffer zone or room and proceeds to the ante area or anteroom. NOTES: 12 of 13 YES NO N/A Before compounding, all work surfaces are cleaned of loose materials and residue from spills followed by an application of a residue-free sanitizing agent that is left on for a time sufficient to exert its antimicrobial effect. Critical area work surfaces are cleaned between batches. Certification for proper function and air quality requirement (Class 100) of each LAFW and barrier isolator is preformed. Date last certified: Air quality of the buffer zone or room and anteroom is evaluated. Date last certified: Compounding personnel perform didactic review and pass written and medial-fill validation testing of aseptic manipulative skills initially and annually thereafter for low-risk and medium-risk level compounding. Refrigerator, freezer and incubator temperatures are checked daily and recorded and equipment problems are addressed promptly. Multiple-dose parenteral medications vials (MDV’s) when used, are refrigerated after opening unless otherwise specified by the manufacturer. Beyond-use dating unless otherwise referenced in the package insert does not exceed 28 days once the vial has been opened. Outdated and unused CSP’s are returned to the pharmacy for disposal or possible reuse. Hazardous drugs are compounded and packaged in one of the following: a properly vented and certified vertical LAFW, or Class II or Class III biological safety cabinet or barrier isolator. Hazardous drugs are labeled with a warning label stating the need for special handling and disposal. Reuse of MDI inhaler mouthpiece by sterilization or cleaning and redispensing to another allowed. Permit the reuse of cartridge components of insulin pens for administration to patients. 13 of 13